Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists

There is evidence of altered vascular function, including cerebrovascular, in Alzheimer's disease (AD) and transgenic models of the disease. Indeed vasoconstrictor responses are increased, while vasodilation is reduced in both conditions. β-Amyloid (Aβ) appears to be responsible, at least in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Dorado, Jorge, Villalba, Nuria, Prieto, Dolores, Brera, Begoña, Martín-Moreno, Ana M., Tejerina, Teresa, de Ceballos, María L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025475/
https://www.ncbi.nlm.nih.gov/pubmed/27695396
http://dx.doi.org/10.3389/fnins.2016.00422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025475/
https://www.ncbi.nlm.nih.gov/pubmed/27695396
http://dx.doi.org/10.3389/fnins.2016.00422

Ejemplares similares